Non Traumatic Neuro-Vascular Diseases Critical Complications : a Prospective Cohort Study
ATLANREA
Prospective Cohort of Patients Hospitalized in West French Intensive Care Units.
1 other identifier
observational
5,000
1 country
6
Brief Summary
The purpose of this observational epidemiological study is to investigate the management and the complications associated with Non Traumatic Neuro-Vascular Diseases. Data will be analysed to answer pre-defined scientific projects and to improve management of these conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2013
Longer than P75 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 16, 2016
CompletedFirst Posted
Study publicly available on registry
March 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2050
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2050
September 30, 2022
September 1, 2022
36.9 years
March 16, 2016
September 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
in ICU stay complications
Hospital acquired infections (epidemiology, risk factors, antibiotic susceptibility of pathogens), Organ failures (incidence, risks factors), Bleeding, Hemorrhage Intra-Cranial Hypertension, Brain Ischemia, Mechanical ventilation weaning, Extubation failure
Within the first 28 days after ICU admission date
Secondary Outcomes (2)
Duration in mechanical ventilation
in ICU (up to 90 days)
ICU length of stay
in ICU (up to 90 days)
Other Outcomes (1)
Death
in ICU (up to 180 days)
Study Arms (1)
ICU patients
Patients with Non Traumatic Neuro-Vascular Diseases. Medical data concerning ICU stay will be collected.
Interventions
A code will be applied to each patient included. Medical data such as demography, Simplified Acute Physiological Score II (SAPS II), Sequential Organ Failure Assessment (SOFA), procedures and complications during ICU stay will be collected.
Eligibility Criteria
Patients hospitalized in ICU for Non Traumatic Neuro-Vascular Diseases
You may qualify if:
- Non Traumatic Neuro-Vascular Diseases
You may not qualify if:
- Consent withdrawal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Angers University Hospital
Angers, 49000, France
CHU de Brest La Cavale Blanche
Brest, 29000, France
Nantes University Hospital
Nantes, 44093, France
Poitiers University Hospital
Poitiers, 86000, France
Rennes University Hospital
Rennes, 35000, France
Tours University Hospital
Tours, 37000, France
Biospecimen
Plasma, serum, peripheral blood mononuclear cells, RNA
Study Officials
- STUDY CHAIR
Karim Asehnoune, PhD, MD
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2016
First Posted
March 21, 2016
Study Start
February 1, 2013
Primary Completion (Estimated)
January 1, 2050
Study Completion (Estimated)
January 1, 2050
Last Updated
September 30, 2022
Record last verified: 2022-09